Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05726487 · ClinicalTrials.gov registry record · NA

Physical Activity Intervention for Black Women With Asthma

A NA study of Asthma, sponsored by University of Chicago.

Active
Registry status
NA
Development phase
224
Enrollment target
2
Study locations

NCT05726487 is a NA study of Asthma that is active but no longer recruiting, run by University of Chicago. The registered enrollment target is 224 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (86% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05726487, a NA study of Asthma, is active but no longer recruiting, sponsored by University of Chicago.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
224 participants
Enrollment target
2
Study locations

Study Summary

Physical inactivity is associated with poor asthma control and quality of life, and greater health care utilization. Rates of physical inactivity, asthma, and asthma mortality among Black women are higher than those of their White counterparts. Our formative work identified barriers to PA among Black women with asthma including a lack of social support, self-efficacy, unsafe neighborhood and fear related to experiences with life-threatening asthma exacerbations. Given the unique barriers to PA and high rates of physical inactivity that are associated with poor asthma outcomes in Black women, there is an urgent need to optimize PA interventions for this population. The proposed study uses our theory-driven intervention (ACTION: A lifestyle physiCal acTivity Intervention for minOrity womeN with asthma) to deliver a 24-week lifestyle physical activity intervention designed for and by urban Black women with asthma. Participants will be recruited through two urban health care systems that care for a diverse urban Black populations. Participants will be randomized to one of two groups: 1) ACTION intervention (group sessions, physical activity self-monitoring and text-based support for goal-setting), or 2) education control (an individual asthma education session and text messages related to asthma education). Participants will be followed for an additional 24-weeks after the intervention to assess for the maintenance of intervention effects on asthma health outcomes. We are proposing an efficacy study that focuses on asthma outcomes (Aim 1A/B), explores behavioral mechanisms of the intervention (Aim 2) and assesses factors that influence its reach and implementation potential (Aim 3). This trial will provide the first ever evidence of the efficacy of a lifestyle physical activity intervention among urban Black women with asthma, a population that is understudied yet plagued by low levels of PA and poor health outcomes. Our study has high potential to advance clinical trea

Conditions Studied

Asthma

Interventions

  • OTHER Education Control
  • BEHAVIORAL ACTION Intervention

Study Locations (2)

Illinois

  • University of Illinois Chicago - Chicago
  • University of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 224 participants
Start Date 2023-05-04
Est. Completion 2026-12-30
Phase NA

Sponsor

University of Chicago

796 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05726487

The ClinicalTrials.gov registry entry for NCT05726487 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 224 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (86% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which Education Control is the first listed.

NCT05726487 reports 2 study locations spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT05726487 about?

NCT05726487 is a clinical study titled "Physical Activity Intervention for Black Women With Asthma". Physical inactivity is associated with poor asthma control and quality of life, and greater health care utilization. Rates of physical inactivity, asthma, and asthma mortality among Black women are higher than those of their White counterparts. Our formative work identified barriers to PA among Blac...

What is the current status of trial NCT05726487?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 224 participants. The study started on 2023-05-04. Estimated completion is 2026-12-30.

What conditions does trial NCT05726487 study?

This clinical trial studies the following conditions: Asthma.

What interventions are being tested in trial NCT05726487?

The interventions under investigation include: Education Control (OTHER), ACTION Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05726487?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05726487 being conducted?

This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Asthma

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.